Chitosan adipate was administered orally to broiler chickens to investigate its effect on body weight and protection against Salmonella gallinarum. The study was conducted on 80 six-day-old broiler chickens from the ROSS line that were divided in four groups (20 birds each): I -control; II -infected with S. gallinarum and treated with chitosan adipate; III -infected with S. gallinarum; IV-chitosan adipate treatment only. Chitosan salt was administered as a feed additive in an amount that guaranteed that the chitosan contained in the salts constituted 3% of the chicken diet. (Phenotypic characteristics of Salmonella gallinarum and Salmonella pullorum isolated from layers). The chickens were infected with a suspension containing 1800x10 6 bacteria in 2 ml (on the McFarland scale gruppe 3). The chickens pretreated orally with chitosan were highly resistant to S. gallinarum infection. The clinical symptoms and anatomicopathological changes in chickens infected with bacteria and treated with chitosan (group II) were weak in comparison with chickens infected with S. gallinarum only (group III). Weight gain was significantly higher (by about 12.5%) in the control group than in the chickens infected with S. gallinarum (group III). In the birds that were infected and treated (group II), and in those that were given chitosan (group IV), weight gain was about 2 -2.5 % lower in comparison with the control group.
Introduction
It has been reported that chitosan, the simplest chitin derivative, exhibits potent immunological activities such as the activation of peritoneal macrophages, the stimulation of non-specific host resistance against Escherichia coli and Sendai virus infection in mice, and the suppression of growth of Meth-A tumor cells in syngeneic mice (NISHIMURA et al., 1984; SAWAYANAKI et al., 1982) . Chitosan is also an attractive preparation to promote the healing of wounds (ALLAN et al., 1984) as it forms a tough, water-absorbent, biocompatible film, which can be applied directly to burns in the form of an aqueous solution of chitosan acetate. Chitosan has also been used to treat whitlow (BRZESKI et al., 1991) . The aim of this study was to determine what protective effect chitosan provides against Salmonella galinarum as well as the impact this compound has on body weight in broiler chickens.
Material and Methods
The study was conducted on 80 six-day-old broiler chickens of the ROSS line weighing 125-130g. The chickens were kept in an electrically heated poultry house, feed and water were supplied ad libitum. The composition of the basal diet was as follows: total protein 18%; fat 8%; crude fiber 4%; methionine 0.4%; cysteine 0.3%; tryptophan 0.18%; lysine 0.9%; calcium 1%; phosphorus 0.5%. The birds were divided into four groups (20 birds each): I -control; II -infected with S. gallinarum and treated with chitosan adipate; III -infected with S. gallinarum; IV-chitosan adipate treatment only. This salt was administered as a feed additive in an amount that guaranteed that the chitosan contained in the salts constituted 3% of the chicken diet. Chitosan adipate was obtained from chitosan with a deacetylation degree of 91.3% and a viscosity average molecular weight 2.18×10 5 g/mol ((WOJTASZ-PAJAK et al., 1998) . The properties of chitosan adipate are presented in Table 1 . 65.9 ± 1.62 Acid content [% d.w.] 27.0 ± 0.12 pH 5.6 ± 0.04 a mean values for n=4 ± standard deviation
The properties of chitosan adipate were determined according to DĄBEK et al. (2004) . Adipic acid met FCC (Food Chemikal Codex) and DAB (Deutsches Arzneibuch) requirements. A standard strain of Salmonella gallinarum from the collection at the Institute of Immunology and Experimental Therapy of the Polish Academy of Sciences was used in this study. A suspension in a saline solution was prepared with a 48h agar culture. Using the McFaerland scale, a concentration of bacteria was established it means that the suspension contained 1800x10 6 Salmonella bacteria in 2 ml. Two ml of this suspension was administered to each bird in groups II and III. Significant differences between the average values of experimental groups were determined by Duncan's multiple range test, run with the STATISTICA PL computer package. Tables 2 -4 , chickens pretreated orally with chitosan were highly resistant to S. gallinarum infection. The clinical symptoms and anatomicopathological changes in chicken infected with bacteria and treated with chitosan (group II) were weak in comparison with those infected with S. gallinarum (group III). In group III, 90% of birds had intensive clinical symptoms, especially diarrhea and apathy (Table  2) . No clinical symptoms or anatomicopathological changes were observed in groups I and IV. The anatomicopathological changes of infected birds are presented in Table 3 . Table 2 .
Results

As shown in
The results of weight gain after the application of chitosan and infection with S. gallinarum are presented in Table 4 . Group I -control; Group II -infected with S. gallinarum and treated with chitosan; Group III -infected with S. gallinarum; Group IV -treated with chitosan A, B, C differences statistically signification at P≤0.01 *chitosan was applied for seven days as a feed additive at a dose of 3% of the diet ** Group II chickens were infected after the application of chitosan. Weight gain was measured seven days after infection (14 days after the application of chitosan).
The weight gain of the control group (I) was significantly higher (about 12.5%) than that in chickens infected with S. gallinarum only (group III). In groups II an IV, weight gain was similar and was about 2 -2.5% lower in comparison with the control group. The weight gain obtained in groups II and IV were about 10.5 -10% higher than that in the infected birds (group III). It was established, that the birds of the control group have a significant (P≤0.01) higher mean weight gain comparing with the other groups. The lowest weight gain was established in birds infected with Salmonella and it was significant (P≤0.01) lower comparing with groups II and IV. Discussion This study focused on the prophylactic properties of chitosan against Salmonella gallinarum infection in chickens. The oral administration of chitosan reduced clinical symptoms and anatomicopathological changes in the digestive tract of infected birds (Tables 2, 3 ). As reported previously by other authors, chitosan has been demonstrated to affect the nonspecific phase in host defense systems such as the accumulation and activation of macrophages and the activation of NK-cells (natural killer cells) and interferon (IFN) in mice (NELSON et al., 1994; RODGERS et al., 1982) . Other studies, including IIDA et al. (1997) , have established that chitosan stimulates nonspecific host resistance against the Sendai virus and Escherichia coli in mice. These authors reported that the intranasal administration of chitosan enhances the production of IFN in the lungs. This would be an important element in the stimulation of host resistance to the Sendai virus infection in mice. In addition to the direct inhibition of virus growth, IFN (interferon) is known to activate macrophages and NK cells that kill virus-infected cells (NISHIMURA et al., 1985; TANAKA et al., 1997) . OKAWA et al., (2003) established that mice pretreated with chitosan exhibited resistance to Pseudomonas aeruginosa and Listeria monocytogenes infection. BALICKA-RAMISZ et al., (2005) performed in vitro testing of the effectiveness of chitosan against four bacterial strains (E. coli, P. aeruginosa, St. aureus, S. paratyphi) and three fungal strains (C. albicans, T. mentagrophytes, M. canis) and demonstrated that chitosan is characterized by high antibacterial and fungicidal activities. The clinical symptoms and anatomicopathological changes observed in the current study correspond well with the results obtained by HERICH et al. (2004) , PROUX et al. (2002), and WIELICZKO et al. (2001) . The livers and spleens were swollen with many necrotic foci. In the chickens that had been treated with chitosan, slight clinical symptoms and anatomicopathological changes were noted only in four birds. NELSON et al. (1994) observed a decreased number of bacteria in the caecum, mesenteric lymph nodes, and livers of mice fed dietary chitosan. These authors reported that a relatively small amount of chitosan in the diet increased the number of Bifidobacterium, but large amounts of chitosan decreased it. The influence of chitosan on weight gain depends on the dose. RAZDAN et al. (1997) established that chicken diets containing 30g/kg of chitosan (89%) significantly reduced body weight and feed intake in comparison with the birds fed control diets. HIRONO et al. (1990) applied a diet of 3.6 g/kg of chitosan for laying hens and established that egg production was lower in comparison with that of the control group. After reducing the chitosan in the laying hen diet to 1.4 g/kg, the authors did not note any negative influence on egg production. The same results were obtained by KOBAYASHI et al. (2002) , and these authors concluded that a low viscosity chitosan supplement can decrease the deposition of dietary fat without reducing food intake or body weight gain in broiler chickens. The present study established that chickens given a 3% chitosan feed additive had slightly decreased weight gain. Seven days after the application of chitosan, the weight of the infected and treated birds (group II) was about 2.5% lower than in the control groups, while that of the birds given chitosan alone the (group IV) was about 2% lower. The weight of the birds infected with S. gallinarum (group III) was lower than the control by 12.5%. The results if the current study concur with the studies of BERNARD et al. (2002) , ALVAREZ (2003) , TANAKA et al. (1997), and LEE (2001) , which reported weight decreases following S. gallinarum infection. It was concluded that orally administered chitosan protected the chickens against Salmonella gallinarum infection. It was also established that low doses of chitosan administered for a short time decreased the weight of the chickens only slightly.
